Lymphoma Diagnosis and Treatment
Lymphoma Diagnosis and Treatment is a research topic within Pathology and Forensic Medicine. Science Explorer counts 66k research works in it since 1950. 14.6% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the classification, molecular profiling, genetic pathogenesis, and treatment strategies for various types of lymphoid neoplasms, including Hodgkin's lymphoma, diffuse large B-cell lymphoma, follicular lymphoma, mantle cell lymphoma, and peripheral T-cell lymphoma. It also explores the use of PET imaging, rituximab therapy, and gene expression profiling to predict survival and guide treatment decisions.
- Lymphoma
- Classification
- Molecular Profiling
- Rituximab
- Genetic Pathogenesis
- PET Imaging
- Hodgkin's Lymphoma
- B-Cell Receptor Signaling
- Mantle Cell Lymphoma
- Gene Expression Profiling
- Research works
- 66k fractional, since 1950
- In the world top 10%
- 9.6k per year above
- Top-10% rate
- 14.6% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +18% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Lymphoma Diagnosis and Treatment research?
By volume, the United States and China publish the most (3.3k and 2k works in 2022–2025).
By volume, 2022–2025
- 1 United States 3.3k works
- 2 China 2k works
- 3 Japan 622 works
- 4 Italy 478 works
- 5 India 427 works
- 6 Germany 426 works
- 7 France 410 works
- 8 United Kingdom 342 works
- 9 Spain 321 works
- 10 Brazil 260 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Lymphoma Diagnosis and Treatment research?
By volume in 2022–2025, The University of Texas MD Anderson Cancer Center publishes the most Lymphoma Diagnosis and Treatment research, followed by Memorial Sloan Kettering Cancer Center and Chinese Academy of Medical Sciences & Peking Union Medical College.
By volume, 2022–2025
- 1 The University of Texas MD Anderson Cancer CenterUnited States 167 works
- 2 Memorial Sloan Kettering Cancer CenterUnited States 93 works
- 3 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 73 works
- 4 Mayo Clinic in ArizonaUnited States 47 works
- 5 Dana-Farber Cancer InstituteUnited States 46 works
- 6 Mayo Clinic in FloridaUnited States 46 works
- 7 Moffitt Cancer CenterUnited States 46 works
- 8 Sun Yat-sen UniversityChina 44 works
- 9 Peking UniversityChina 42 works
- 10 Stanford UniversityUnited States 39 works
Who are the leading researchers in Lymphoma Diagnosis and Treatment?
The most-cited researchers publishing on Lymphoma Diagnosis and Treatment include Todd R. Golub, Lawrence H. Schwartz and Hagop M. Kantarjian.
- 1 Todd R. Golub United States 6.8k citations
- 2 Lawrence H. Schwartz United States 5.8k citations
- 3 Hagop M. Kantarjian United States 4k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Lymphoma Diagnosis and Treatment research done?
The largest centres of Lymphoma Diagnosis and Treatment research in 2022–2025 are Beijing (China), New York (United States), Houston (United States) and Shanghai (China). Among places with at least 20 works in it, it is an unusually large share of all research in Duarte and Lancaster.
Largest cities, 2022–2025
Where it is the local speciality
- DuarteUS · 32.5 works53×
- LancasterUS · 30.8 works36×
Location quotient: how much more of its research is in Lymphoma Diagnosis and Treatment than the world average.
Where is the best place to study Lymphoma Diagnosis and Treatment?
Among universities, judged by research, Tokai University, Weill Cornell Medicine and Vita-Salute San Raffaele University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Tokai UniversityJapan | 55.1 | 24.3% | 8.1× | 9 | +91.8% |
| 2 | Weill Cornell MedicineUnited States | 51.2 | 13.5% | 10.1× | 14 | — |
| 3 | Vita-Salute San Raffaele UniversityItaly | 51.2 | 21.7% | 7.2× | 10 | +54.4% |
| 4 | Università degli Studi del Piemonte Orientale “Amedeo Avogadro”Italy | 50.8 | 23.5% | 8.8× | 8 | -22.4% |
| 5 | Medical University of LodzPoland | 49.5 | 29.6% | 5.5× | 9 | +21.7% |
| 6 | Kettering UniversityUnited States | 47.1 | 7.3% | 44.4× | 18 | +71.9% |
| 7 | Medical College of WisconsinUnited States | 45.9 | 13.5% | 6.1× | 17 | +146.0% |
| 8 | Nanjing Medical UniversityChina | 44.9 | 9.6% | 6.9× | 38 | +74.6% |
| 9 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 43.7 | 7.0% | 7.0× | 73 | +15.0% |
| 10 | Heinrich Heine University DüsseldorfGermany | 43.4 | 17.8% | 3.5× | 11 | +166.0% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Lymphoma Diagnosis and Treatment research growing?
Output in 2018–2022 was 18% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Lymphoma Diagnosis and Treatment.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.